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a b s t r a c t 
Background: Preterm birth ( < 37 weeks), low birth weight (LBW, < 2500g), and small for gestational age 
(SGA, < 10th centile of birth weight for gestational age and sex) are markers of newborn vulnerability with 
a high risk of mortality. We estimated the prevalence of phenotypes combining these three markers and 
quantified the mortality risk associated with them. 
Methods: Population-based cohort study using routine register-based linked data on all births and deaths 
in Brazil from January 1, 2011, to December 31, 2018. We estimated the prevalence of preterm, LBW, and 
SGA individually and for phenotypes combining these characteristics. The mortality risk associated with 
each phenotype: early neonatal, late neonatal, neonatal, post-neonatal, infant, 1-4 years, and under five 
years was quantified using mortality rates and hazard ratios (HRs) with 95% confidence interval (CI) were 
estimated using Cox proportional hazard models. 
Findings: 17,646,115 live births were included. Prevalence of preterm birth, LBW and SGA were 9.4%, 
9.6% and 9.2%, respectively. Neonatal mortality risk was 16-fold (HR = 15.9; 95% CI:15.7–16.1) higher for 
preterm compared to term, 3 times higher (HR = 3.4; (95% CI:3.3–3.4) for SGA compared to adequate for 
gestational age (AGA), and > 25 times higher for LBW (HR = 25.8; (95% CI:25.5-26.1) compared to nor- 
mal birth weight (NBW). 18% of all live births were included in one of the small vulnerable newborn 
phenotypes. Of those 8.2% were term-SGA (4.7%NBW, 3.5%LBW), 0.6% were term-AGA-LBW, 8.3% preterm- 
AGA (3.8%NBW, 4.5%LBW) and 1.0% preterm-SGA-LBW. Compared to term-AGA-NBW, the highest mortal- 
ity risk was for preterm-LBW phenotypes (HR = 36.2(95%CI 35.6-36.8) preterm-AGA-LBW, HR = 62.0(95%CI 
60.8-63.2) preterm-SGA-LBW). The increased mortality risk associated with vulnerable newborn pheno- 
types was highest in the first month of life, with attenuated but continued high risk in the post-neonatal 
period and 1-4 years of age. 
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Research in context 
Evidence before this study 
Previous studies have shown the increased risk of neona- 
tal and infant mortality among low birth weight (LBW, birth 
weight below 2500g), preterm (birth before 37 gestational 
weeks) and SGA ( < 10th centile of birth weight for gestational 
age and sex) infants. However, these studies assume homo- 
geneity within each of these groups even though substan- 
tial differences may exist and that babies can be classified in 
more than one group. For the Lancet Vulnerable Newborn se- 
ries, Ashorn et al. (2020) recently highlighted the importance 
of closing gaps in knowledge and defined detailed vulnerable 
newborn phenotypes by combining preterm, SGA, and LBW. 
Added value of this study 
In this population-based study of nearly 17.6 million live 
births, we estimated that prevalences of preterm birth, SGA 
and LBW individually were around 9%. However, 18% of all 
live births were included in one of the small vulnerable new- 
born phenotypes, and 1% were simultaneously preterm, LBW 
and SGA. These newborns were the most vulnerable, with 
the highest mortality risk 62 times greater compared to term 
babies who were not LBW or SGA. The increased mortality 
risks associated with preterm birth, SGA and LBW were most 
marked in the first month of life, however, some increased 
risk remained up to 1-4 years. 
Implications of all the available evidence 
To our knowledge, this analysis combining the three phe- 
notypes (namely preterm birth, SGA and LBW) as proposed 
has not been presented before. The proposed approach pro- 
vides more granular information by moving beyond simplistic 
dichotomous cut-offs, which could better support research on 
causal pathways and mechanisms to distinguish between the 
several phenotypes. The great variety observed in the mor- 
tality risk highlights the importance of this work, enabling 
better monitoring and management of small vulnerable new- 
borns, optimising interventions, and enhancing resource al- 
location, delivering preventive and curative procedures and 
programming for those most in need. Therefore, the findings 
of this study are of public health importance and have the 
potential to contribute towards faster progress to achieving 
Sustainable Development Goals (SDGs) and Global Nutrition 
targets. 
. Introduction 
Preterm birth (birth before 37 gestational weeks), small for ges- 
ational age (SGA, < 10th centile of birth weight for gestational 
ge and sex) (a proxy of intrauterine growth restriction), and low 
irth weight (LBW, birth weight below 2500g) are markers of new- 
orn vulnerability with short and long-term outcomes [ 1 ]. LBW 
an be due to being preterm and/or intrauterine growth restric- 
ion. Each year it is estimated that 20.5 million newborns are 2 pport the value of using more detailed phenotypes to identify those at
a can inform care at the individual level, advance research, especially for
ress towards global targets such as the Sustainable Development Goals. 
© 2021 The Author(s). Published by Elsevier Ltd. 
icle under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
orn LBW - 15.5% of all births worldwide, however, around 80% 
f neonatal deaths occur in this group. Newborns who are both 
reterm and small for gestational age (SGA) are at 15 times greater 
ortality risk than those born at term and with appropriate size 
or gestational age (AGA) (between 10 th and 90 th centile) and sex 
 2–6 ]. In addition to increased mortality risk, small size at birth 
s associated with increased neonatal morbidity, childhood stunt- 
ng and developmental delays, with lifelong consequences, includ- 
ng chronic health disorders and reduced human capital [ 7–9 ]. 
LBW has often been used as an indicator of newborn suscepti- 
ility; however, in general, most countries’ routine statistical data 
o not distinguish between newborns with intrauterine growth re- 
triction (IUGR) (typically defined by the proxy, SGA) from those 
orn preterm. Although there are national (and hence regional and 
lobal) estimates for the prevalence of preterm birth [ 12 ], LBW 
 5 , 10 ], there are much fewer comparable data on SGA with limited
stimates for low- and middle-income countries based on only 23 
tudies [ 6 ]. There is a lack of data combining vulnerability of new- 
orns using these three parameters (preterm birth, LBW, and SGA) 
o give more detailed phenotypes. 
Previous studies have shown the increased risk of neonatal 
nd infant mortality among LBW, preterm and SGA infants [ 2 , 11 ].
owever, these studies assume homogeneity within each of these 
roups even though substantial differences may exist, and babies 
an fall in more than one group. For the Lancet Vulnerable New- 
orn series, Ashorn et al. (2020) recently highlighted the impor- 
ance of closing gaps in knowledge and defined detailed vulnerable 
ewborn phenotypes by combining preterm, SGA, and LBW [ 12 ]. 
 consortium is working on multi-country analyses to inform esti- 
ates of vulnerable newborn phenotypes and mortality population 
ttributable risk [ 12 ]. This study uses national Brazilian linked data 
n more than 17 million live births over seven years. It aims to: 
1 Estimate the prevalence of preterm, LBW, and SGA separately 
and for the detailed vulnerable newborn phenotypes. 
2 Quantify the mortality risk (early neonatal, late neonatal, 
neonatal, post-neonatal, infant mortality, and under five years 
mortality) for each defined small vulnerable newborn pheno- 
type. 
Findings will be useful to inform policies and individual level 
are, advance research, especially for prevention, and accelerate 
rogress towards global targets, such as the Sustainable Devel- 
pment Goals (SDGs) on ending preventable newborn and child 
eaths by 2030 and the WHO global nutrition targets for 2025, 
hich include a 30% reduction in LBW [ 13 , 14 ]. 
. Methods 
We conducted a population-based electronic cohort study by 
inking routine data on live births with records of deaths in Brazil 
rom January 1, 2011, to December 31, 2018. The data consist of 
ive births followed up until the age of five years old, death or up 
o December 31, 2018 – whichever was first. 
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.1. Data sources 
We obtained data from the national Live Birth Information 
ystem- SINASC (Sistema de Informação sobre Nascidos Vivos), and 
ational Mortality Information System-SIM (Sistema de Informação 
obre Mortalidade) in Brazil from 2011-2018. 
The SINASC is an information system that records data from the 
eclaration of Live Birth, a legal document completed by the health 
orker who attends the delivery. It covers over 98% of the Brazilian 
erritory [ 15 ] and includes information on the mother (e.g., mater- 
al age, schooling, marital status, and ethnicity); pregnancy infor- 
ation (e.g., antenatal appointments, length of gestation, multiple 
etuses); and information on the newborn (e.g., birth weight, sex) 
 16 ]. 
Death-related information was obtained from SIM where all 
eaths are recorded. SIM includes information on the deceased and 
n the deceased’s mother. As of 2011, SIM was estimated to cover 
ver 97% of all deaths in Brazil [ 15 ]. 
.3. Linkage process 
Since there is no unique identifier in the Brazilian Information 
ystem, we linked SINASC live births records with deaths regis- 
ered in SIM using the name of the mother, maternal date of birth 
r age (when date of birth was missing), and the municipality of 
esidence of the mother as matching variables. The linkage was 
erformed with CIDACS-RL-Record Linkage [ 17 ], a novel record- 
inkage tool developed to link large-scale administrative Brazilian 
atasets. Linkage procedures were conducted at the centre in a 
trict data protection environment and according to ethical and le- 
al rules [ 18 ]. CIDACS-RL applies the combination of indexing and 
earching algorithms implemented in Apache Lucene solution as 
he blocking strategy. The indexation strategy allows the CIDACS-RL 
o search the most similar records from the Indexed SIM for each 
ecord in SINASC and submit them to the pairwise comparisons 
tep. Candidate linking records are ordered by the scores, and only 
he comparison pair with the highest score is retained as a poten- 
ial link. All remaining candidate records are discarded. A sample 
f 20 0 0 pairs stratified in three categories of linkage score (high 
core – above 0.95, intermediate score – values between 0.90 and 
.95, and low score - below 0.90) was obtained and manually re- 
iewed to evaluate the linkage quality. In this validation process, 
e obtained a mean sensitivity and specificity of over 93%. 
.4. Data processing, exclusions, and definitions 
According to the SINASC guideline, gestational age is deter- 
ined using either ultrasound, last menstrual period or clinical 
xamination and the birth weight should be measured within 5 
ours after the birth. Once the data were linked, we excluded 
ecords with a missing gestational age at birth, birth weight, or 
ewborn sex for whom it is not possible to assess size for gesta- 
ional age. We also excluded implausible birth weights defined as 
 350g or ≥ 6500g. Low birth weight was defined as birth weight 
 2500 g, normal birth weight (NBW) as birthweight ≥2500g and 
 6500g, preterm birth as a gestational age < 37 completed weeks, 
erm as gestational age ≥37 weeks and < 42 weeks, and small for 
estational age (SGA) defined as < 10 th centile for birth weight 
or gestational age in completed weeks at birth by sex using the 
NTERGROWTH-21 st international newborn size standards [ 19 ] and 
ppropriate size for gestational age (AGA) between 10th and 90th 
entiles. The INTERGROWTH-21 st international newborn size stan- 
ards are from 24 to < 43 weeks gestational age, and therefore we 
lso excluded observations < 24 weeks or ≥43 weeks at birth [ 19 ].
hose classified as large for gestational age (above the 90 th cen- 
ile using the INTERGROWTH-21 st ) were excluded since this paper 3 ocuses on small newborns, and large babies will be studied in a 
ubsequent analysis. 
After all exclusions, live births were classified according to 
utually exclusive phenotypes based on combinations of LBW, 
reterm birth and SGA [ 12 ]. The phenotypes are: term + AGA + 
BW; term + SGA + NBW; preterm + AGA + NBW; term + AGA + LBW;
erm + SGA + LBW; preterm + AGA + LBW; and preterm + SGA + LBW.
erm + AGA + NBW was used as the reference group. We further re- 
lassified phenotypes into a binary variable: those not small (term 
 AGA + NBW) and those small (all remaining phenotypes). 
We classified mortality as early neonatal (from birth up to 6 
ays), late neonatal (7-27 days), neonatal (from birth up to 27 
ays), post-neonatal (28–364 days), infant mortality (birth to 364 
ays), mortality between one to four years (after the first year of 
ife up to five years) and under-five mortality (from birth up to five 
ears). 
.5. Statistical analyses 
We estimated the prevalences of preterm, SGA and LBW indi- 
idually and each combined vulnerable newborn phenotype. De- 
criptive statistics are presented for maternal sociodemographic 
ata and newborn characteristics. Mortality rates (deaths/1,0 0 0 
erson-year (PY) and crude hazard ratios (HRs) with 95% were es- 
imated using Cox regression. Kaplan-Meier curves were plotted 
o compare the mortality by phenotype. We adjusted for mater- 
al age, maternal race/ethnicity, marital status, maternal educa- 
ion, sex of newborn, multiple pregnancy, presence of congenital 
bnormalities detected at birth, and mode of delivery. We also con- 
ucted a sensitivity analysis, excluding newborn with congenital 
bnormalities. Data analyses were performed in Stata version 15.0. 
Ethical approval was obtained from the Federal University of 
ahia’s Institute of Public Health Ethics Committee (CAAE registra- 
ion number: 18022319.4.0 0 0 0.5030). 
.6. Role of the Funding Source 
Wellcome Trust (205377/Z/16/Z). ESP is funded by the Well- 
ome Trust Grant number 213589/Z/18/Z; ASR is funded by the 
razilian Federal Agency for Support and Evaluation of Graduate 
ducation (CAPES). FJOA is funded by the Bahia Research Sup- 
ort Foundation. This research was funded by the Wellcome Trust 
Grant number; 202912/Z/16/Z]. NIHR Grant number 122844. The 
unders had no role in study design, analysis, decision to publish 
r preparation of the manuscript. 
. Results 
During the study period, from January 1 st 2011, to Decem- 
er 31 2018, 23,439,789 live births were registered in SINASC. Of 
hese, 5,793,674 (24.7%) were excluded, 2,044,638 (8.7%) due to 
issing data, 13,790 (0.1%) due to implausible birth weight val- 
es, 285,360 (1.2%) gestational age < 24 weeks or ≥43 weeks at 
irth and 3,449,938 (14.7%) large for gestational age ( Figure 1 ). A 
igher percentage of missing information on core variables (birth 
eight, gestational age at birth and newborn sex) were observed 
mong live births of mixed race and indigenous, single, less edu- 
ated mothers (supplementary Table S2). 
Overall, 9.4% of all included live births were born preterm, 9.2% 
ere SGA, and 9.6% were LBW. Over 40% of all preterm births were 
GA and born with a normal birth weight (preterm + AGA + NBW: 
.8% of all live births), while 4.5% of all live births were preterm, 
GA and LBW. The prevalence of LBW combined with SGA among 
erm live births was 3.5%, and 0.6% of live births were term, LBW 
nd AGA. The prevalence of term, SGA, and NBW was 4.7%, and 1% 
f all births were preterm, SGA, and LBW newborns ( Figure 1 ). 
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In general, the prevalence of small live births (those with at 
east one of the characteristics i.e., preterm birth, SGA and LBW) 
as higher in mothers younger than 20 years (n = 675,571, 20.7%) 
nd older than 35 years (n = 451,445, 20.3%), among indigenous 
nd black (n = 27,233, 22.2%; 192,615, 20.2% respectively), widows 
nd single mothers (n = 5,983, 19.4%; n = 1,406,328, 19.0% respec- 
ively), and less educated women (n = 24,623, 25.4%). About 38% of 
he small vulnerable babies had a congenital abnormality ( Table 1 ). 
he characteristics of live births by each of the phenotypes are pre- 
ented in supplementary Table S1. 
The mortality risk was higher in the early neonatal period, with 
early three-quarters (72.3%) of all neonatal deaths and 44.3% of 
ll under-five deaths occurring in this period (n = 86,357) ( Table 1 ).
ortality risk decreased substantially in the post-neonatal and 1–
-year periods but remained elevated for all small phenotypes 
ompared to ‘non-small’ peers. The overall adjusted neonatal mor- 
ality risk was over 15 times greater among preterm when com- 
ared to term newborns (HR = 15.9; 15.7-16.1), 3-fold among SGA 
hen compared to AGA (HR = 3.4; 3.3-3.4), and 25-fold among LBW 
hen compared to NBW (HR = 25.8; 25.5-26.1) live births ( Table 2 ).
Figure 3 shows Kaplan-Meier curves for the likelihood of death 
n the study population from birth up to five years. The probability 
f death increased rapidly during the neonatal period. The high- 
st risk is observed among preterm + SGA + LBW newborns, with 
2% dying before the 28 th day of life and 16% dying before five 
ears. Among preterm + AGA + LBW there was also a high probabil- 
ty of death at around 6% during the neonatal period and 7% dying 
ithin five years. 
The mortality risk varied markedly from one phenotype to an- 
ther. Higher mortality risks were seen in those phenotypes, in- 
luding more than one feature of preterm, SGA and LBW. Live 
irths at term, SGA, with NBW were 2.3 (95% IC 2.2-2.4) more 
ikely to die than term, AGA and NBW ( Table 3 ). The neonatal mor-
ality risk was substantially higher among live births with pheno- 
ypes that combined preterm birth and LBW, i.e., adjusted neonatal 
ortality was 36-fold among preterm, AGA live births that were 4 BW (HR = 36.2; 95% IC 35.6-36.8) and was 62-fold among those 
reterm, SGA and LBW (HR = 62.0; 95% IC 60.8-63.2) compared 
o term, adequate for gestational age and NBW. Infant and under- 
ve mortality were 23-fold and 19-fold higher among preterm, 
GA live births that were LBW and 39-fold and 32-fold higher 
mong those preterm, SGA and LBW compared to term, AGA and 
BW ( Table 3 ). The relative mortality risk fell substantially for 
ost-neonatal and 1–4-year, 9-fold and 2.6-fold among preterm, 
GA live births that were LBW and 16-fold and 4-fold among 
hose preterm, SGA and LBW compared to term, AGA and NBW 
 Figure 2 ). The analysis restricted to newborns without congeni- 
al abnormalities showed slightly lower relative mortality for most 
f the phenotypes and a higher relative mortality for the smallest 
ewborns (preterm + AGA + LBW and preterm + SGA + LBW) (supple- 
entary Table 3). 
. Discussion 
In this population-based study of nearly 17.6 million live births 
ver eight years in Brazil the prevalences of preterm birth, SGA 
nd LBW were around 9%. The mortality associated with being 
orn preterm or LBW was higher than for SGA. We estimated that 
8% of all live births were included in one of the small vulnerable 
ewborn phenotypes. While only 1% were simultaneously preterm, 
BW and SGA, these newborns were the most vulnerable, with the 
ighest mortality risk at 62-fold compared to term babies who 
ere not LBW or SGA. As the preterm-LBW combination is likely 
o be a proxy of lower gestational ages, this finding further sup- 
orts the importance of gestational age in neonatal mortality risk. 
he increased mortality risks associated with preterm birth, SGA 
nd LBW were most marked in the first month of life, but some 
ncreased risk remained up to 1-4 years. 
The elevated all-cause and cause-specific mortality risk associ- 
ted with preterm birth is well known in both high-income [ 11 , 20–
6 ] countries and from LMIC datasets [ 2 , 6 , 27 ]. The higher risk
or neonates who are both preterm and SGA has also been de- 
E.S. Paixao, H. Blencowe, I.R. Falcao et al. The Lancet Regional Health - Americas xxx (xxxx) xxx 
ARTICLE IN PRESS 
JID: LANAM [m5G; September 1, 2021;21:16 ] 
Table 1 
Characteristics of 17,646,115 delivering live birth included in this study in Brazil from 2011-2018 by vulnerability status. 
Characteristics Not Small live births ∗ Small live births ∗∗ Total births Prevalence of Small live births 
Maternal age (years) 
< 20 years 2,592,357 675,571 3,267,928 20.7 
20-35 10,085,172 2,073,674 12,158,846 17.1 
> 35 1,767,728 451,445 2,219,173 20.3 
Maternal ethnicity 
White 5,251,965 1,107,267 6,359,232 17.4 
Black 761,388 192,615 954,003 20.2 
Asian 58,165 12,696 70,861 17.9 
Mixed race 7,700,328 1,719,443 9,419,771 18.3 
Indigenous 98,233 27,994 126,227 22.2 
Marital status 
Single 5,977,909 1,406,328 7,384,237 19.0 
Married/union 8,132,186 1,718,753 9,850,939 17.4 
Widow 24,936 5,983 30,919 19.4 
Divorced 156,961 35,497 192,458 18.4 
Maternal education 
None 72,304 24,623 96,927 25.4 
1-3 years 403,719 111,272 514,991 21.6 
4-7 years 2,646,788 667,899 3,314,687 20.1 
8-12 years 8,436,419 1,812,841 10,249,260 17.7 
≥ 12 years 2,683,797 537,768 3,221,565 16.7 
Multiples fetuses 
Yes 108,573 312,882 421,455 74.2 
None 14,316,826 2,883,468 17,200,294 16.8 
Sex of newborn 
Male 7,378,763 1,647,549 9,026,312 18.3 
Female 7,066,610 1,553,193 8,619,803 18.0 
Congenital abnormalities 
Yes 91,520 55,997 147,517 38.0 
None 14,022,232 3,067,722 17,089,954 18.0 
Mode of delivery 
Caesarean section 7,947,149 1,745,066 9,692,215 18.0 
Vaginal Delivery 6,482,878 1,452,186 7,935,064 18.3 
Neonatal deaths 
Yes 26,140 93,366 119,506 78.1 
No 14,378,412 3,070,718 17,449,130 17.6 
Early Neonatal deaths 
Yes 17,885 68,472 86,357 79.3 
No 14,378,412 3,070,718 17,449,130 17.6 
Late Neonatal deaths 
Yes 8,255 24,894 33,149 75.1 
No 14,378,412 3,070,718 17,449,130 17.6 
Post Neonatal deaths 
Yes 25,209 29,727 54,936 54.1 
No 14,378,412 3,070,718 17,449,130 17.6 
Infant Mortality 
Yes 51,349 123,093 174,442 70.6 
No 14,378,412 3,070,718 17,449,130 17.6 
Under five mortality 
Yes 65,348 129,489 194,837 66.5 
No 14,378,412 3,070,718 17,449,130 17.6 
1-4 mortality 
Yes 13,999 6,396 20,395 31.4 
No 14,378,412 3,070,718 17,449,130 17.6 
∗ Not Small live births = T + AGA + NBW, 
∗∗ Small live births = all remain phenotypesIn view of the very large sample size in our dataset, all between group comparisons 
are highly significant with very low p-values. 
Table 2 
Mortality risk by age group associated with preterm birth, small for gestational age (SGA) and low birth weight (LBW), Brazil 2011-2018. 
Mortality 
risk 
Preterm birth ∗ SGA # LBW $ 
HR (95%CI) HR (95%CI) HR (95%CI) 
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Early Neonatal Mortality (birth to 6 days) 19.9 (19.6-20.1) 17.3 (17.1-17.6) 4.4 (4.3-4.4) 3.4 (3.3-3.4) 30.5 (30.1-30.9) 27.8 (27.4-28.2) 
Late Neonatal Mortality (7-27 days) 14.1 (13.8-14.4) 12.6 (12.3-12.9) 4.1 (4-4.2) 3.3 (3.2-3.4) 22.7 (22.2-23.1) 21.0 (20.5-21.5) 
Post Neonatal Mortality (28-364 days) 5.1 (5-5.2) 4.4 (4.4-4.5) 3.4 (3.3-3.4) 2.7 (2.7-2.8) 8.2 (8.1-8.3) 7.3 (7.2-7.4) 
1-4 years ( ≥1 - < 5 years) 1.9 (1.8-1.9) 1.7 (1.7-1.8) 2.0 (1.9-2.1) 1.8 (1.7-1.9) 2.6 (2.5-2.6) 2.4 (2.3-2.5) 
Neonatal Mortality (birth to 28 days) 18.2 (18-18.4) 15.9 (15.7-16.1) 4.3 (4.2-4.4) 3.4 (3.3-3.4) 28.2 (27.9-28.5) 25.8 (25.5-26.1) 
Infant Mortality (birth to 364 days) 12.2 (12.1-12.3) 10.6 (10.5-10.7) 4.0 (4.0-4.0) 3.2 (3.1-3.2) 19.1 (18.9-19.2) 17.2 (17.1-17.4) 
Under five mortality (birth up to 5 years) 10.3 (10.2-10.4) 9.0 (8.9-9.0) 3.8 (3.7-3.8) 3.0 (3.0-3.0) 15.8 (15.7-15.9) 14.3 (14.2-14.4) 
∗ Reference group 37 + , 
$ Reference group 2500 + , 
# Reference group Adequate for gestational age. 
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Figure 2. Cox proportional hazards for mortality risk comparing the different phenotypes. 


















cribed in several papers [ 2 , 6 , 27 , 28 ]. However, to our knowledge,
his analysis combining the three phenotypes (preterm birth, SGA 
nd LBW) as proposed by Ashorn et al. (2020) [ 12 ] has not been
resented before. By moving beyond the simplistic dichotomous 
ut-offs, the proposed approach provides more granular informa- 
ion which could better support research on causal pathways and 
echanisms to distinguish between the several phenotypes [ 12 ]. 
he great variety observed in the mortality risk highlights the im- 
ortance of this work. It should enable better monitoring and man- 6 gement of small vulnerable newborns, optimising interventions, 
nd enhancing resource allocation, delivering preventive and cura- 
ive procedures and programming for those most in need. There- 
ore, the findings of this study are of public health importance and 
ave the potential to contribute to faster progress towards Sus- 
ainable Development Goals (SDGs) and Global Nutrition targets 
 13 , 14 , 29 ]. 
Most LMIC studies on mortality risk associated with preterm 
irths, intrauterine growth restriction and LBW include neonatal 
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7 eaths and sometimes infant deaths [ 2 , 6 , 27 ], with more limited
ata on long-term sequelae [ 30 ]. Although in our cohort over 61% 
f deaths occurred in the neonatal period (first 28 days), an in- 
reased mortality risk persisted into early childhood and at least 
p to 5 years of age, as previously described [ 26 ]. Longer follow- 
p would be important to estimate the risk during late childhood, 
dolescence, and adulthood. 
Our study has strengths and weaknesses. This population-based 
ohort has a very large sample size with sufficient power to assess 
ortality even for lower prevalence phenotypes. We also had in- 
ormation on covariates, which enabled control for several poten- 
ial confounders. There are, however, limitations. First, the miss- 
ng data were not distributed randomly: for example, a higher per- 
entage of missing information was observed among more vulner- 
ble groups, such as indigenous and less educated women. Since 
isks of small size at birth and associated mortality are likely to 
e higher in these vulnerable populations, this may add biases. 
econdly the preterm births data in SINASC-Brazil have previously 
een found to underestimate the population preterm birth rate 
y 15% [ 31 ]. Third, the linkage process to identify deaths could 
ave introduced classification bias due to linkage errors (missed 
atches or false matches). However, such linkage errors are prob- 
bly non-differential, so misclassification of deaths should not vary 
ccording to gestational age or birth weight, and are therefore un- 
ikely to introduce bias in the estimated hazard ratio, although the 
bsolute measures of risk may be underestimated. Fourth, resid- 
al confounding is possible because we only had a limited num- 
er of possible confounders to analyse, and data on maternal co- 
orbidities, quality or type of obstetric care might ideally have 
een adjusted for. Finally, we did not explore the duration of ges- 
ation and the birth weight other than classifying newborns into 
ichotomous variables. However, as previous research has shown, 
ortality varies markedly, very steep for lower gestational ages 
nd birth weight. In future analyses it would be important to fur- 
her improve our understanding of these cut-offs for mortality pre- 
iction purposes, including analysing using continuous interaction 
ariables. Finally, although we conducted a sensitivity analyses ex- 
luding the group with congenital abnormalities an investigation 
ocused exclusively on this group should be conducted.Ultimately 
GA was not as predictive of mortality as preterm and low birth- 
eight, and these more granular phenotypes better illuminate the 
ariation in risk. Such evidence can inform research on causal 
athways and help to better target interventions, such as early 
etection of risk, improved hospital based small and sick new- 
orn care linked to comprehensive child nutrition and health, all of 
hich can improve the survival of small and vulnerable newborns 
n LMICs and guide progress towards a decline in child mortality. 
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